[Ref] Other Very common (10% or more): Pain (35%), flu syndrome (29%), chest pain (15%), accidental injury (12%), asthenia (12%), fever (12%) Common (1% to 10%): Peripheral edema, weight decrease, weight increase Very rare (less than 0.01%): Body odor, International Normalized Ratio (INR) increased [Ref] Local Very common (10% or more): Injection site reaction (38%) [Ref] Musculoskeletal Musculoskeletal side effects, in chronic hemodialysis patients, for levocarnitine (the active ingredient contained in L-Carnitine) in relation to placebo therapy have included asthenia (8% to 12% vs 8%) and leg cramps (4% to 8% vs 13%)
In summary, CsInTe 2 - R 3 m offers a desirable combination of ductility, thermal stability, and manageable anisotropy, making them promising candidates for flexible applications
Activation of alpha-1 leads to the (i) contraction of the iris dilator and Mullers muscles, leading to mydriasis and lid retraction, (ii) vasoconstriction causing the restriction of blood flow to the ciliary muscle, and (iii) reduced aqueous humor production [215]
[DOI] [PMC free article] [PubMed] [Google Scholar] Cheng L, Deepak RNVK, Wang G, Meng Z, Tao L, Xie M, et al
10.1074/jbc.274.4.2234 81
Carnitine palmitoyltransferase 1A has a lysine succinyltransferase activity